PHILADELPHIA, Aug. 20,
2024 /PRNewswire/ -- IntegriChain, the leading
provider of revenue optimization technology and insights for the
pharmaceutical industry, today announced the appointment of
Matt Heyman as Chief Financial
Officer. Heyman brings IntegriChain more than a decade of
experience in corporate finance, strategy, and M&A,
predominately within public and private software businesses.
"IntegriChain is poised for significant growth in the coming
years as we focus on our mission – to help pharma innovators
develop, implement, and operate sustainable growth strategies for
life-changing science," said Josh
Halpern, Co-Founder and CEO of IntegriChain. "We are
thrilled to have Matt join us with his depth of experience in
corporate finance and development, growing SaaS companies, and
partnering with strategic investors."
"I am excited to join the IntegriChain leadership team at this
pivotal moment," said Heyman. "The company has developed into a
leading platform that uniquely combines data, technology,
outsourcing, and consulting to address the essential challenges of
drug commercialization in today's market. I look forward to helping
IntegriChain execute its vision organically and inorganically as we
continue to build out the ICyte Platform and arm our pharma
customers with the keys they need to deliver renewed growth."
About Matt Heyman
Heyman will be responsible for IntegriChain's Global Finance and
Accounting operations. He previously held numerous leadership roles
at Diligent Corporation over the last eight years, most recently as
the Senior Vice President, Finance and Corporate Development.
During his tenure at Diligent, revenue increased fivefold, and he
led numerous strategic acquisitions. Prior to Diligent, Heyman
served on the corporate development team at the SaaS business
Fleetmatics (NYSE:FLTX) through a successful acquisition by
Verizon. He began his career in the investment banking and
management consulting industries. Heyman earned a BA degree in
economics from The George Washington
University.
About IntegriChain
IntegriChain helps pharma
manufacturers bring their science to market, ensuring patients have
affordable, timely, and sustainable access to therapy. IntegriChain
delivers Pharma's only data-driven commercialization platform —
from strategy to operational execution. The Company's unique focus
on data, technology, consulting, and outsourcing helps connect the
commercial, financial, and operational dimensions of drug access
and profitability. Through the ICyte Platform, IntegriChain enables
pharmaceutical innovators to achieve better commercial outcomes by
digitalizing daily and recurring business activities and by
integrating data and operations across contracting, pricing,
channel and distribution, and gross-to-net. IntegriChain is backed
by Nordic Capital, a leading sector-specialized private equity
investor with a broad portfolio in Healthcare and Technology.
IntegriChain's umbrella of companies include Blue Fin Group
and Federal Compliance Solutions, and the company is
headquartered in Philadelphia, PA,
with offices in Ambler, PA, and
Pune, India. For more information,
visit www.integrichain.com or follow on LinkedIn.
Contact
Jennifer Guinan
| Sage Strategic Marketing | jennifer@sagestrat.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/integrichain-appoints-experienced-high-growth-finance-executive-as-cfo-302225806.html
SOURCE IntegriChain
